Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Blood Specimen Collection × 30 days × Clear all

Phase

Phase NA 17 Phase 1 3 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 49 Carboplatin 36 Specimen Handling 33 Magnetic Resonance Spectroscopy 30 Biopsy 30 Cyclophosphamide 29 Nivolumab 23 Dexamethasone 22 fludarabine 21 Gemcitabine 19 Bevacizumab 19 Paclitaxel 18 venetoclax 16 Pemetrexed 16 Rituximab 13 Cisplatin 13 atezolizumab 12 Temozolomide 12 Cetuximab 12 Azacitidine 12 Lenalidomide 11 Prednisone 10 Vincristine 9 Irinotecan 9 Fulvestrant 9 fludarabine phosphate 8 durvalumab 8 carfilzomib 8 aldesleukin 8 X-Rays 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04454528 2026-03-10

BreastVAX

Abramson Cancer Center at Penn Medicine

Phase 1/2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡